1503 / 1835
When RT should be considered in “advanced-stage”?
•
With regimens with less excessive chemotherapy (ABVD X6;
BEACOPP X6, Stanford V)
•
Older patients (>50) who tolerate intensive/long
chemotherapy poorly.
•
Patients with contra-indications for aggressive chemotherapy
•
Patients with predominantly bulky site(s) ????
•
Patients with residual disease that remain PET (+)
•
Field: CTV is post-chemo volume
•
Dose: 30 Gy (
36 Gy- 40 Gy under special circumstances)
47